We provide you with 20 years of free, institutional-grade data for SPPI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SPPI. Explore the full financial landscape of SPPI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Spectrum Pharmaceuticals, Inc(NASDAQ:SPPI) 
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include ROLONTIS, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a nov...
Website: http://www.sppirx.com
Founded: 1987
Full Time Employees: 146
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about SPPI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.